by In2Pharma | Jun 21, 2022 | News
Luxembourg Since 1st of May 2022 the notification of food supplements in Luxembourg should be done electronically. Since that date, the platform MyGuichet.lu is available without authentication and therefore accessible to all companies. No file submitted on paper or...
by In2Pharma | Jun 21, 2022 | News
Europe EMA published 2 updates of guidelines related to (traditional) herbal medicinal products: Specifications: test procedures and acceptance criteria for herbal substances, herbal preparations and herbal medicinal products/traditional herbal medicinal products:...
by In2Pharma | Jun 21, 2022 | News
Europe At the end of January, EU Regulation 536/014 “Clinical trials” went into force. The entry into force of this Regulation resulted in the parallel updating of some international guidelines. In particular, a new version of the GMP Guide PE016 was...
by In2Pharma | Jan 7, 2021 | News
The Netherlands As of 1st January 2021, the Medicines Evaluation Board (MEB) will increase the fees for marketing authorization applications and changes the annual fee for medicines for human use and the fees for consultation procedures. The fees for veterinary...
by In2Pharma | Jan 7, 2021 | News
Belgium The FAMHP’s fees have been updated and corrected for the indexation of January 2021. All concerned updated fees can be found here. Source: FAMHP
